Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 01, 2019 14:51 ET | Source: American Gene Technologies

American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa

ROCKVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Cell & Gene Meeting...
July 02, 2019 16:33 ET | Source: American Gene Technologies

HIV Cure Program of American Gene Technologies Adds University of Maryland School of Medicine’s Institute of Human Virology as New Study Site to Support the Development of a Cell and Gene Therapy for HIV

ROCKVILLE, Md., July 02, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at...
May 21, 2019 08:30 ET | Source: American Gene Technologies

HIV Cure Program Patent Granted To American Gene Technologies

ROCKVILLE, Md., May 21, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies, a leading gene and cell therapy company based in Rockville, Md., was granted a second patent for its unique molecule,...
March 28, 2018 08:30 ET | Source: American Gene Technologies

American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention

ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today congratulates Robert R. Redfield, M.D., on his...
March 19, 2018 08:30 ET | Source: American Gene Technologies

American Gene Technologies Gains Additional Immuno-Oncology Patent

ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology...
January 25, 2018 09:30 ET | Source: American Gene Technologies

American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure

ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its...
December 12, 2017 09:00 ET | Source: American Gene Technologies

American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells

ROCKVILLE, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No:...
October 12, 2017 09:00 ET | Source: American Gene Technologies

American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection

ROCKVILLE, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (“AGT”), a gene therapy and technology company focusing on a lentiviral delivery platform, presented...
September 26, 2017 09:00 ET | Source: American Gene Technologies

American Gene Technologies Inc. (AGT) CSO, David Pauza, to Present HIV Functional Cure data At The Cell & Gene Meeting on the Mesa

ROCKVILLE, Md., Sept. 26, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that...
September 11, 2017 12:29 ET | Source: American Gene Technologies

American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors

ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right